@article{fdi:010073781,
  title = {{T}he creation and evolution of the donor funded market for antimalarials and the growing role of southern firms},
  author = {{O}rsi, {F}abienne and {S}ingh, {S}. and {S}agaon {T}eyssier, {L}uis},
  editor = {},
  language = {{ENG}},
  abstract = {{S}ince the early 2000s, the question of access to medicines at affordable prices for {S}outhern populations has appeared as one of the major challenges for the international governance of health. {B}ut what is at stake is the creation of market for medicines in the global {S}outh, particularly countries in the {S}ub-{S}aharan {A}frica. {T}hese markets are new in nature in the sense that they are driven by international organisations where {S}outhern firms, especially from {I}ndia, occupy an increasingly important position. {H}owever, the specificity of these markets and the way they are constituted have been little analysed. {I}n this article, we suggest focusing the attention on the constitution of the market of antimalarial drugs and highlighting the role played by {S}outhern firms in this market. {O}ur study focuses on the public sector market of antimalarial drugs. {W}e provide an institutional and quantitative analysis of the creation of this public market. {W}e then discuss the growing importance of the {S}outhern firms, mainly {I}ndian and {C}hinese, in this market.},
  keywords = {{AFRIQUE} {SUBSAHARIENNE} ; {CHINE} ; {INDE} ; {MONDE} ; {PAYS} {EN} {DEVELOPPEMENT}},
  booktitle = {},
  journal = {{S}cience {T}echnology and {S}ociety},
  volume = {23},
  numero = {3},
  pages = {349--370},
  ISSN = {0971-7218},
  year = {2018},
  DOI = {10.1177/0971721818762906},
  URL = {https://www.documentation.ird.fr/hor/fdi:010073781},
}